Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic β-cells

Endocrinology

Volumn 145, Issue 6, 2004, Pages 3023-3031

  Ubeda, Mariano ^a   Kemp, Daniel M ^a   Habener, Joel F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CYCLIN DEPENDENT KINASE 5; GLUCOSE; MESSENGER RNA; PROTEIN P35; ROSCOVITINE; SMALL INTERFERING RNA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE COURSE; ENDOCRINE CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; CELL LINE; CULTURE TECHNIQUES; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; GLUCOSE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; NERVE TISSUE PROTEINS; OSMOLAR CONCENTRATION; PRECIPITIN TESTS; PROTEIN KINASES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 2542461194     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1522     Document Type: Article

References (33)

1. Hoppener JW, Ahren B, Lips CJ 2000 Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343:411-419
2. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH 1999 Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-622
3. Le Dourain NM 1988 On the origin of pancreatic endocrine cells. Cell 53:169-171
4. Alpert S, Hanahan D, Teitelman G 1988 Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53:295-308
5. Deltour L, Leduque P, Blume N, Madsen O, Dubois P, Jami J, Bucchini D 1993 Differential expression of the two non-allelic proinsulin genes in the developing mouse embryo. Proc Natl Acad Sci USA 90:527-531
6. Devaskar SU, Singh BS, Carnaghi LR, Rajakumar PA, Giddins SJ 1993 Insulin-II gene expression in rat central nervous system. Regul Pept 48:55-63
7. Perez-Villamil B, Schwartz PT, Vallejo M 1999 The pancreatic homeodomain transcription factor IDX1/IPF1 is expressed in neural cells during brain development. Endocrinology 140:3857-3860
8. Ashford ML, Boden PR, Treherne IM 1990 Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K channels. Pflugers Arch 415:479-483
9. + channels. Br J Pharmacol 101:531-540
10. Thor S, Ericson J, Brannstrom T, Edlund T 1991 The homeodomain LIM protein isl-1 is expressed in a subset of neurons and endocrine cells in the adult rat. Neuron 7:881-889
11. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC 2004 Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474-481
12. Peila R, Rodriguez BL, Launer LJ 2002 Type 2 diabetes, APOE gene, and risk for dementia and related pathologies. Diabetes 51:1256-1262
13. Andrews B, Measday V 1998 The cyclin family of budding yeast: abundant use of a good idea. Trends Genet 14:66-72
14. Dhavan R, Tsai LH 2001 A decade of cdk5. Nat Rev Mol Cell Biol 2:749-759
15. Van den Heuvel S, Harlow E 1993 Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054
16. Nikolic M, Tsai LH 2000 Activity and regulation of p35/Cdk5 kinase complex. Methods Enzymol 325:200-213
17. Meijer L, Borgne A, Mulner O, P. Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP 1997 Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536
18. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP 1997 Biochemical and cellular effects of roscovotine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536
19. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH 1994 A brain-specific activator of cyclin-dependent kinase 5. Nature 371:423-426
20. Chou KC, Watenpaugh KD, Heinrikson RL 1999 A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. Biochem Biophys Res Commun 259:420-428
21. Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, Hatase O, Wang JH 1995 An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 270:26897-26903
22. Gao CY, Zakeri Z, Zhu Y, He H, Zelenka PS 1997 Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens. Dev Genet 20:267-275
23. Fu AK, Fu WY, Cheung J, Tsim KW, Ip FC, Wang JH, Ip NY 2001 Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 4:374-381
24. Lilja L, Yang SN, Webb DL, Juntti-Berggren L, Berggren PO, Bark C 2001 Cyclin-dependent kinase 5 promotes insulin exocytosis. J Biol Chem 276:34199-34205
25. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings Jr HC, Nairn AC, Greengard P 1999 Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402:669-671
26. Harada T, Morooka T, Ogawa S, Nishida E 2001 ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol 3:453-459
27. Paglini G, Pigino G, Kunda P, Morfini G, Maccioni R, Quiroga S, Ferreira A, Caceres A 1998 Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J Neurosci 18:9858-9869
28. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P 2001 Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410:376-380
29. Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF 1998 Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 797:267-277
30. Nguyen MD, Lariviere RC, Julien JP 2001 Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30:135-147
31. Kuusisto J, Koivisto K, Mykkanen L, Helkaka E, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laasko M 1997 Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein e4 phenotype: cross-sectional population-based study. Br Med J 315:1045-1049
32. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ 1997 Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145:301-308
33. Ott A, Stolk RP, van Hardkamp FH, Pols AP, Hofman A, Breteler MMB 1999 Diabetes mellitus and the risk of dementia. Neurology 53:1937-1942